BXCL501: Targeting Alpha2-Adrenrgic Receptors for Neuropsychiatric Symptoms

Time: 12:55 pm
day: Day One


• Stress activates Noradrenergic Signaling and may precipitate psychiatric symptoms
• Alpha2-Adrenergic Receptors Regulate noradrenergic signaling
• BXCL501 is designed to activate alpha2-adrenergic receptors and thereby alleviate the symptoms caused by overactive noradrenergic signaling
• BXCL501 rapidly and effectively reduced agitation in patients with schizophrenia or bipolar disorder